Chilblain Lupus 1 C0024145
A lupus-related skin condition causing painful red or purple bumps on fingers and toes when exposed to cold. It primarily affects people with lupus, often women. Symptoms typically improve with warmth and may be managed with lupus medications.
Key facts at a glance
- ICD-10
- L98.9
- ICD-11
- EA00.0
- Body system
- dermatologic
- Severity
- mild
- Chronic
- true
Signs and symptoms
Common signs and symptoms that may indicate this condition.
Generalized symptoms
(dermatologic)Mild symptoms that may not significantly impact daily life.
Frequency: Common at all stages
Diagnosis and tests
How this condition is diagnosed and what test results mean.
Initial screening tests
Standard diagnostic workup
Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]
Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]
Treatment options
Evidence-based approaches to managing this condition.
First-line treatments
Cold Protection and Environmental Modification
Primary preventive strategy involving wearing insulated gloves, warm footwear, and layered clothing. Keep indoor environments consistently warm and avoid rapid temperature transitions.
Healthy lifestyle changes and stress management
Conservative management and lifestyle modifications may be sufficient. Monitor symptoms.
Calcium Channel Blockers
Systemic vasodilators such as nifedipine that improve peripheral blood flow by relaxing vascular smooth muscle. First-line pharmacotherapy for chilblain lesions.
Additional treatment options
Topical Corticosteroid Therapy
Application of medium-potency topical steroids to inflamed chilblain lesions to reduce local inflammation, itching, and discomfort during acute flares.
medicationSmoking Cessation
Complete tobacco cessation essential for improving peripheral microcirculation. Nicotine constricts blood vessels and significantly impairs healing of chilblain lesions.
lifestyleNifedipine or Diltiazem with Nutritional Support
Combination approach pairing vasodilator medication with supplements such as omega-3 fatty acids and vitamin E to support vascular health and reduce inflammation.
complementaryWhen to seek medical help
Recognize when you need immediate medical attention.
Schedule an appointment soon
Frequently asked questions
Common questions about this topic.
What is Chilblain Lupus 1 C0024145?
Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]
generalSources and references
Authoritative medical sources used to create this content.
Kuhn A, Amler S, Beissert S, et al. Updated guideline of the German Society of Dermatology for the treatment of cutaneous lupus erythematosus. J Dtsch Dermatol Ges. 2020.
Viguier M, Jachiet M, Bouaziz JD, et al. Clinical features, outcomes and treatment in patients with chilblain lupus: a systematic review. Ann Rheum Dis. 2022.
Dorazilova A, Skabytska Y, Morelli E, et al. Pathophysiology of chilblain lupus: Type I interferon signature and vasculopathy. Lupus Sci Med. 2021.
Millard TP, McGregor JM. Chilblains and lupus erythematosus: a review of the literature. Clin Exp Dermatol. 2019.
Medication Comparisons
Compare medications used to treat Chilblain Lupus 1 C0024145. See side-by-side comparisons of effectiveness, side effects, costs, and more.
View Medication ComparisonsThis information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.
This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.
If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.
Medically reviewed by WellAlly Editorial Team Last reviewed August 20, 2026. · Read our editorial policy